Xuzhou Medical University won the Silver Award at the 25th China Patent Award

On June 5, the State Intellectual Property Office announced the "Decision of the State Intellectual Property Office on the 25th China Patent Award". The authorized patent of Professor Zheng Junnian's team of the School of Cell Therapy Drug Industry of our school "a full-human chimeric antigen receptor, iNKT cells that target B7H3 to co-express IL-21" and won the Silver Award of China Patent. This is the first time that Xuzhou Medical University has won the award, marking the national recognition of the school's scientific and technological innovation and intellectual property protection in the field of cell therapy.

The China Patent Award is co-organized by the State Intellectual Property Office and the World Intellectual Property Organization. It is the only government department award in China that specializes in awarding inventions and creations for patents. Among the 769 China Patent Awards winning projects of this year, there are 60 patent silver awards in China, including only 12 university projects.

The award-winning general-purpose CAR-iNKT cell technology is another core achievement of Professor Zheng Junnian's team since he obtained the first CAR-T authorized patent in China and the successful treatment of hematologic tumors and autoimmune diseases. (Author: Zhou Lishi)